Indirect ultrasound evaluation of left ventricular outflow tract diameter implications for heart failure and aortic

Gabriele Pestelli1,2, Andrea Fiorencis3, Valeria Pergola4

  • 1Cardiology Unit, Morgagni-Pierantoni Hospital, Forlì, Italy.

Insights

A new formula predicts left ventricular outflow tract diameter (LVOTD) using aortic root and LV dimensions, improving accuracy over body surface area (BSA) alone. This enhances assessments in heart failure (HF) and aortic stenosis (AS).

Area of Science:

  • Cardiology
  • Echocardiography
  • Medical Imaging

Background:

  • Left ventricular outflow tract diameter (LVOTD) dependency on body surface area (BSA) is established.
  • The relationship between LVOTD and aortic root/left ventricular (LV) dimensions is unexplored.
  • Accurate LVOTD assessment is crucial for heart failure (HF) and aortic stenosis (AS) evaluation.

Purpose of the Study:

  • To explore the relationship between LVOTD and aortic root/LV dimensions.
  • To develop a novel predictive equation for LVOTD incorporating these dimensions.
  • To compare the novel equation with the existing BSA-derived formula.

Main Methods:

  • A cohort of 540 HF patients underwent transthoracic echocardiography.
  • Patients were divided into derivation (N=340) and validation (N=200) subgroups.
  • A regression equation was derived using independent determinants of LVOTD and validated.

Main Results:

  • Sinuses of Valsalva diameter (SVD), BSA, LV end-diastolic diameter (LVEDD), and height were independent LVOTD determinants.
  • The novel regression equation (LVOTD = 6.209 + [0.201 × SVD] + [1.802 × BSA] + [0.03 × LVEDD] + [0.025 × Height]) showed high correlation with measured LVOTD (R=0.739).
  • The novel equation performed significantly better than the BSA-derived formula.

Conclusions:

  • Aortic root and LV dimensions independently influence LVOTD.
  • A new comprehensive equation incorporating these dimensions improves LVOTD prediction.
  • This advancement aids LV output evaluation in HF and AS severity assessment when direct measurement is challenging.
Abstract

Related Concept Videos

Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
146
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
62
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
108